# Quant Analyst

- Symbol: CIEN
- Elapsed: 44.7s

---
## CIEN — Quantitative Factor Analysis

**Ciena Corporation** · Technology / Communication Equipment · Price **$284.34** · Mkt cap **~$40.3–41.3B** · Book value/share $18.79 · 145.2M diluted shares

⚠️ **Data-quality note up front:** the sector-peer endpoint returned mega-cap *Technology* names (AAPL, NVDA, MSFT, AVGO…), not communication-equipment comparables, so cross-sectional **sector ranks below are estimated quintiles vs. the comm-equipment sub-industry**, not true peer-z-scores. Treat them as directional.

---

### 1. Factor Scores Table

| Factor | Score (0–100, est.) | Sector Rank (est.) | Signal |
|--------|--------------------|--------------------|--------|
| **Value** | ~5 | Bottom quintile | **Deeply expensive** — P/E 334, P/B 15.1, EV/EBITDA 107, P/FCF 62 |
| **Momentum** | ~40 | Middle (split) | **Mixed/negative** — 12-1 momentum −0.32% (flat), but explosive *recent* 1-month surge |
| **Quality** | ~38 | Lower-middle | **Low** — ROE 4.5%, ROIC 7.2%; offset by strong accruals (−0.116) |
| **Low Vol** | ~3 | Bottom quintile | **Very poor** — 80.7% ann. vol, beta 2.83, max DD 54.7% |
| **Earnings Revision** | ~80 (face) / low confidence | Top (but n=2) | **Upgrade +41%** — but only 2 analysts on a 2030 estimate |

**Raw factor inputs**
- Value: P/E 334.5 · P/B 15.13 · EV/EBITDA 107.0 · P/FCF 62.1 · div yield n/a
- Quality: ROE 4.52% · gross-profit/assets 0.342 · accruals ratio **−0.116** (cash-backed earnings, a genuine plus) · Piotroski F-score **6/9** (moderate; docked on leverage, equity issuance, and gross-margin trend)
- Low-vol: ann. vol 80.67% · beta 2.834 · max DD −54.65%
- Momentum (252d, 12-1): **−0.32%**
- Earnings revision: 2030E EPS $34.97 vs $24.72 prior → **+41.5%**; **but only 2 analysts** cover 2029–2030

---

### 2. Price Statistics

| Metric | Value |
|--------|-------|
| Alpha (annualised, vs SPY) | **+23.2%** |
| Beta (vs SPY) | **2.85** |
| R² (vs SPY) | **0.21** — only 21% of variance is market; 79% idiosyncratic |
| Sharpe ratio | **0.60** (vol-based tool reports 0.73 — see note) |
| Sortino ratio | **0.88** |
| Annualised return (252d) | +48.2% |
| Annualised volatility | 80.7% |
| Max drawdown | −54.7% |

⚠️ **Sharp internal inconsistency that matters:** annualised return is +48% but 12‑1 momentum is **−0.32%**. This implies essentially *all* of the trailing-year return was delivered in the **last ~21 trading days** — a parabolic, short-window squeeze. Standard momentum (which excludes that window) is flat-to-negative. This is a classic **momentum-reversal / late-stage-chase flag**, and it's why the two Sharpe figures differ (0.60 vs 0.73): the risk-adjusted record is dominated by a single recent spike.

---

### 3. Composite Quant Signal: **SELL** (factor-based)

The data do **not** support buying on a systematic basis:
- **Value is in the bottom ~1%** (P/E 334) — the market is pricing several years of flawless execution.
- **Low-vol factor is a disaster** (80% vol, beta 2.8) — poor risk-adjusted profile.
- **Quality is low** (ROE 4.5%, ROIC 7.2%) — the balance-sheet accruals are clean, but returns on capital are thin.
- **Momentum is flat/negative** on the robust 12‑1 measure; the only strong "momentum" is a recent spike that is precisely the reversal-risk zone.
- **Earnings revisions are positive on paper (+41%)**, but sit on a **2-analyst, 2030 estimate** — statistically unreliable.

**Honest caveat:** the +23% annualised alpha shows the stock *has* outrun the market; this is a growth/story name where the model's fair value depends heavily on the delivery of an aggressive EPS ramp (consensus FY2027 $11.85 → FY2028 $17.53 → FY2029 $24.72 → FY2030 $34.97). At today's $284 that implies forward P/E ~24x on 2027E and ~16x on 2028E — reasonable *if* the ramp lands, but the factor model penalises the valuation and volatility risk you're underwriting to get there.

---

### 4. Key Quant Risk Flags

1. **Momentum reversal / parabolic-spike risk (high):** the entire 12-month gain is concentrated in the last month; 12‑1 momentum is negative. Chasing here has poor statistical expectancy.
2. **Factor crowding into "growth/vol":** beta 2.85 and 80% vol mean outsized drawdown exposure — already demonstrated by a 54.7% max drawdown in the past year.
3. **Valuation extreme:** P/E 334, P/B 15, EV/EBITDA 107. Any EPS disappointment de-rates violently given the multiple.
4. **Revision signal is low-confidence:** n=2 analysts on far-dated estimate; the +41% "upgrade" is not robustly supported. Do not over-weight.
5. **Liquidity:** large-cap (~$40B), so liquidity is fine — this is *not* a liquidity risk; the risks are valuation and volatility.
6. **Low R² (0.21):** returns are idiosyncratic — sector/beta hedges won't protect you; single-name event risk dominates.

**Bottom line:** On a pure quantitative-factor basis CIEN scores in the **worst quintile on value and low-vol**, **low on quality**, and only **weak/mixed on momentum**, with the lone positive (revisions) being statistically fragile. Composite quant signal = **Sell**; the bull case rests entirely on fundamental growth delivery, not on the numbers as they stand.
